|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gender-strati- fled analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian eohorts显示文摘 | Browning BL Annese V Barclay ML | 2008 | J Med Genet2008，45，1： | 1 |
| 2 | Morphometric evaluation of the contractile apparatus in primary cultures of rabbit cardiac myocytes 显示文摘 | Decker ML Behnke- Barclay M Cook MG | 1991 | Circ Res1991，69，1： | 1 |
| 3 | Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine显示文摘 | Roberts RL Barclay ML | 2004 | Pharmacogenetics2004，14，11： | 1 |
| 4 | Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors显示文摘 | Stedman CA Barclay ML | 2000 | Aliment Pharmacol Ther2000，14，： | 1 |
| 5 | Comparison of the pharma cokinetics,acid suppression and efficacy of proton pump inhibitors显示文摘 | Stedman CA Barclay ML | 2000 | Aliment Pharmacol Ther2000，14，： | 1 |
| 6 | IMPDH1 promoter mu- tations in a patient exhibiting azathioprine resistance 显示文摘 | Roberts RL Gearry RB Barclay ML | 2007 | Pharmacog- enomics J2007，7，5： | 1 |
| 7 | Comparison of the pharma cokinetics,acid suppression and efficacy of proton pump inhibitors显示文摘 | Stedman CA Barclay ML | 2000 | Aliment Pharmacol Ther2000，14，： | 1 |
| 8 | Review article: comparison of the pharmaeokineties, acid suppression and efficacy of proton pump inhibitors 显示文摘 | Stedman CA Barclay ML | 2000 | Allment Pharmacol Ther2000，14，8： | 1 |
| 9 | Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease显示文摘 | Gearry RB Barclay ML | 2005 | J Gastroenterol Hepatol2005，20，8： | 1 |
| 10 | Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease显示文摘 | Gearry RB Barclay ML | 2005 | J Gastroenterol Hepatol2005，20，8： | 1 |
| 11 | The therapeutic monitoring of antimicrobial agents显示文摘 | BEGG E J BARCLAY ML KIRKPATRICK CM | 1999 | Br J Clin Pharmacol1999，47，1： | 1 |
| 12 | Comparison of the phamla cokinetics, acid suppression and efficacy of proton pump inhibitors显示文摘 | Stedman CA Barclay ML | 2000 | Aliment Pharamacol Ther2000，14，： | 1 |
| 13 | Submeatal surface electromyographic measurement and pharyngeal pressures during normal and effortful swallowing 显示文摘 | Huckabee ML Butler SG Barclay M | 2005 | Arch Phys Med Rehabil2005，86，11： | 1 |
| 14 | Review article: comparison of the phar- macoktics, acid suppression and efficacy of proton pump inhibitors 显示文摘 | Stedman CAM Barclay ML | 2000 | Aliment Pharm Therap2000，14，： | 1 |
| 15 | Review article : comparison of the pharmacoki - netics,acid suppression and efficacy of proton pump inhibitors显示文摘 | Stedman CAM Barclay ML | 2000 | Aliment Pharmacol Ther2000，14，8： | 1 |
| 16 | Review article:Comparison of the pharma cokinetics, acid suppression and efficacy of proton pump inhititors显示文摘 | Stedman CA Barclay ML | 2000 | Aliment Pharmacol Ther2000，14，： | 1 |
| 17 | The therapeutic monitoring of an-timicrobial agents显示文摘 | Barclay ML Kirkpatrick CM | 2001 | Br J Clin Pharmacol2001，，1： | 1 |
| 18 | Review article:comparison of the phar-macokinetics,acidsuppression and efficacy of proton pump inhibitors显示文摘 | Stedman CA Barclay ML | 2000 | Aliment Dharmacol Ther2000，14，： | 1 |
| 19 | Revier article:comparison of the pharmacokinetics,acid suppression and efficacy of proton pump inhibitors显示文摘 | Stedman CA Barclay ML | 2000 | Aliment Pharmacol Ther2000，14，8： | 1 |
| 20 | Submental surface electromyographic measurement and pharyngeal pressures during normal and effortful swallowing显示文摘 | Huckabee ML Butler SG Barclay M | | 0，，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员